Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Clinical trial NCT04521686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04521686
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-07-17
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.